from The American Heritage® Dictionary of the English Language, 4th Edition
- n. An antibody that reacts with the cells, tissues, or native proteins of the individual in which it is produced.
from Wiktionary, Creative Commons Attribution/Share-Alike License
- n. An antibody formed in response to an agent (autoantigen) produced by the organism itself
from WordNet 3.0 Copyright 2006 by Princeton University. All rights reserved.
- n. an antibody acting against tissues of the organism that produces it
Sorry, no etymologies found.
Antinuclear/anticytoplasmic antibodies: screening test, specific autoantibody tests, and LE cell preparation
Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
In 2003, they published a landmark study showing that of those servicemen and women who did develop lupus, 88 percent had at least one autoantibody to lupus ten years prior to diagnosis.
Endocrine disruptors environmental estrogens enhance autoantibody production by B1 cells.
For more on the complexities of predicting who will have the disease based on autoantibody testing in autoimmune diseases in general, please see chapter 5, “The Autoimmune Disease Detectives.”
This disease can be diagnosed by the presence of a specific self-attacking immune protein-an autoantibody referred to as NMO-IgG-in the blood.
A comprehensive evaluation of thyroid function and autoantibody production is the best way to diagnose this disease.
To summarise it: some diabetes sufferers have an autoantibody that's responsible for their resistance to insulin, and the Pambakians supposed that, as insulin resistance is so uniquely destructive, if they could derive a peptide from the autoantibody, it would be uniquely curative.
C57BL/6, BALB/c, SJL, F1, and SWR mice strains. 3-4 However, the exact pathological role and action of anti-mouse PLP (139-151) and anti-PLP (178-191) autoantibody is not well understood. 1-4
Thus, future therapeutic assays involving immunomodulation as a first line treatment will reasonably be targeted first to patients with an autoantibody-mediated severe ADAMTS13 deficiency.